Truist Financial Boosts Integer (NYSE:ITGR) Price Target to $150.00

Integer (NYSE:ITGR) had its price target increased by Truist Financial from $145.00 to $150.00 in a research note published on Monday, Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Other equities research analysts have also issued research reports about the stock. Benchmark reissued a buy rating and issued a $130.00 price target on shares of Integer in a report on Wednesday, October 2nd. Citigroup raised their price target on shares of Integer from $124.00 to $130.00 and gave the stock a neutral rating in a report on Tuesday, October 1st. Oppenheimer began coverage on shares of Integer in a report on Tuesday, July 16th. They issued an outperform rating and a $135.00 price target on the stock. Finally, Bank of America raised their price target on shares of Integer from $135.00 to $145.00 and gave the stock a buy rating in a report on Tuesday, October 1st. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of Moderate Buy and an average price target of $138.00.

Integer Price Performance

Shares of Integer stock opened at $132.43 on Monday. Integer has a 52-week low of $69.40 and a 52-week high of $132.68. The stock has a market capitalization of $4.44 billion, a price-to-earnings ratio of 45.82, a price-to-earnings-growth ratio of 1.86 and a beta of 1.08. The company has a fifty day moving average of $125.46 and a 200-day moving average of $120.24. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.24 by $0.06. Integer had a net margin of 6.31% and a return on equity of 11.48%. The company had revenue of $436.20 million during the quarter, compared to analysts’ expectations of $437.00 million. During the same quarter in the prior year, the company earned $1.14 EPS. The firm’s revenue was up 9.0% on a year-over-year basis. Equities research analysts expect that Integer will post 5.3 EPS for the current year.

Insider Transactions at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now directly owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Corporate insiders own 2.00% of the company’s stock.

Institutional Investors Weigh In On Integer

Several institutional investors and hedge funds have recently modified their holdings of ITGR. Vanguard Group Inc. lifted its position in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock valued at $446,428,000 after acquiring an additional 23,382 shares during the period. Earnest Partners LLC lifted its position in Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares during the period. Congress Asset Management Co. MA lifted its position in Integer by 7.5% during the 1st quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after acquiring an additional 31,736 shares during the period. Driehaus Capital Management LLC lifted its position in Integer by 62.5% during the 2nd quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after acquiring an additional 135,750 shares during the period. Finally, Tributary Capital Management LLC lifted its position in Integer by 0.3% during the 2nd quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after acquiring an additional 772 shares during the period. 99.29% of the stock is owned by hedge funds and other institutional investors.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.